NCT04909567

Brief Summary

Colorectal cancer is one of the most common cancers globally. A majority are operated on for the purpose of cure. Complications after surgery are common, involve long length of stay and increase the risk of later recurrence of cancer. Optimization of physical and mental function before surgery can reduce the risk of complications and provide a faster recovery. However, a standardized form for how optimization should be performed does not exist. At Danderyd Hospital, Stockholm, Sweden, we are starting up an optimization center where patients are offered optimizing measures while waiting for surgery. This form of structured treatment has not been studied before and we therefore want to investigate outcomes in a randomized study. All patients with colorectal cancer who are being examined for surgery are offered participation in the study. Randomization of 518 patients in to either an intervention group where the patients; are optimized for concomitant diseases, treated for malnutrition and overconsumption of alcohol and tobacco, undergoes an exercise program and receives psychosocial support before surgery, or a control group where patients are prepared for surgery according to current routines. Primary outcome is the difference in severe complications between the groups. Secondary outcome is difference in length of stay as well as fitness and mental well-being before and 30 days after the operation.If optimization before surgery reduces complications and shortens length of stay, the model can also be used by other operating specialties. This may result in a great improvement for the healthcare in general.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
518

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 26, 2021

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 1, 2021

Completed
5 months until next milestone

Study Start

First participant enrolled

October 26, 2021

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2025

Completed
Last Updated

March 10, 2023

Status Verified

March 1, 2023

Enrollment Period

3.9 years

First QC Date

May 26, 2021

Last Update Submit

March 9, 2023

Conditions

Keywords

ERASRCTOptimisation

Outcome Measures

Primary Outcomes (1)

  • Serious complications

    Can preoperative optimization change the proportion of serious complications after surgery (defined according to Clavien 3b-5) in intervention vs. control arm. ) in intervention vs. control arm

    30 days

Secondary Outcomes (5)

  • Reoperations

    30 days

  • Length of stay (LOS)

    30 days

  • Working capacity

    2-12 weeks

  • Weight loss

    2-12 weeks

  • Psychosocial status

    2-12 weeks

Study Arms (2)

Intervention arm

EXPERIMENTAL

Optimisation: Diet, organised exercise, psychosocial support

Behavioral: Optimisation

Control arm

NO INTERVENTION

Current standard preparation before surgery

Interventions

OptimisationBEHAVIORAL

Defined optimisation

Intervention arm

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All patients, 18 years or older, with strong suspicion of colorectal cancer

You may not qualify if:

  • Patients with dementia with severe cognitive impairment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ulf Oskar Gustafsson

Stockholm, 18288, Sweden

RECRUITING

MeSH Terms

Conditions

Postoperative Complications

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Ulf Gustafsson, MD, PhD

    Karolinska Institutet

    PRINCIPAL INVESTIGATOR
  • Josefin Karlsson, Nurse

    Karolinska Institutet

    STUDY CHAIR

Central Study Contacts

Klas Pekkari, MD, PhD,

CONTACT

Helene Vibom, nurse

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Randomized controlled study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor of Surgery

Study Record Dates

First Submitted

May 26, 2021

First Posted

June 1, 2021

Study Start

October 26, 2021

Primary Completion

September 1, 2025

Study Completion

September 1, 2025

Last Updated

March 10, 2023

Record last verified: 2023-03

Data Sharing

IPD Sharing
Will not share

Data Availability Statement Due to Swedish legal restrictions and the current ethical approval for the study, data is not publicly available to share, but the research group can provide descriptive data in table form.

Locations